Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound

US11832509B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11832509-B2
Application numberUS-202016898744-A
CountryUS
Kind codeB2
Filing dateJun 11, 2020
Priority dateJun 13, 2019
Publication dateNov 28, 2023
Grant dateNov 28, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound. M 1 (L 11 ) n11 (L 12 ) n12   <Formula 1> wherein L 11 in Formula 1 is a ligand represented by Formula 1-1, and the descriptions of other substituents are the same as described in the detailed description of the present application:

First claim

Opening claim text (preview).

What is claimed is: 1. An organometallic compound represented by Formula 1: M 1 (L 11 ) n11 (L 12 ) n12   <Formula 1> wherein, in Formula 1, M 1 is a first-row transition metal of the Periodic Table of Elements, a second-row transition metal of the Periodic Table of Elements, or a third-row transition metal of the Periodic Table of Elements, L 11 is a ligand represented by Formula 1-1, L 12 is a monodentate ligand or a bidentate ligand, n11 is 1, and n12 is 0, 1, or 2; wherein, in Formula 1-1, *1 to *4 each indicate a binding site to M 1 ; A 10 is an N-containing heterocyclic group, A 20 , A 30 , and A 40 are each independently a C 5 -C 30 carbocyclic group or a C 1 -C 30 heterocyclic group, T 1 is a single bond, *—N[(L 1 ) a1 -(R 1 ) b1 ]—*′, *—B(R 1 )—*′, *—P(R 1 )—*′, *—C(R 1 )(R 2 )—*′, *—Si(R 1 )(R 2 )—*′, *—Ge(R 1 )(R 2 )—*′, *—S—*′, *—Se—*′, *—O—*′, *—C(═O)—*′, *—S(═O)—*′, *—S(═O) 2 —*′, *—C(R 1 )═C(R 2 )—*′, *—C(═S)—*′, or *—C≡C—*′, T 2 is a single bond, *—N[(L 2 ) a2 -(R 3 ) b3 ]—*′, *—B(R 3 )—*′, *—P(R 3 )—*′, *—C(R 3 )(R 4 )—*′, *—Si(R 3 )(R 4 )—*′, *—Ge(R 3 )(R 4 )—*′, *—S—*′, *—Se—*′, *—O—*′, *—C(═O)—*′, *—S(═O)—*′, *—S(═O) 2 —*′, *—C(R 3 )═C(R 4 )—*′, *—C(═S)—*′, or *—C≡C—*′, L 1 and L 2 are each independently a single bond, a substituted or unsubstituted C 5 -C 30 carbocyclic group, or a substituted or unsubstituted C 1 -C 30 heterocyclic group, a1 is an integer from 1 to 3, and when a1 is 2 or more, two or more of L 1 (s) are identical to or different from each other, a2 is an integer from 1 to 3, and when a2 is 2 or more, two or more of L 2 (s) are identical to or different from each other, X 11 is C(R 11 ) or N, X 12 is C(R 12 ) or N, X 20 is C or N, X 30 is C or N, X 40 is C or N, X 21 , X 22 , X 31 , X 32 and X 41 are each independently C or N, and Ar 1 is a substituted or unsubstituted C 5 -C 30 carbocyclic group, and when Ar 1 is a benzene group, An is represented by one of Formulae Ar1-1 to Ar1-18, wherein, in Formulae Ar1-1 to Ar1-18, E 11 to E 15 are each independently a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 1 -C 60 alkylthio group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkylaryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and E 16 and E 17 are each independently a substituted or unsubstituted C 6 -C 60 alkyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 1 -C 60 alkylthio group, a substituted C 3 -C 10 cycloalkyl group, an unsubstituted C 7 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted C 6 -C 60 aryl group, an unsubstituted C 7 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkyl aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, R 1 to R 4 , Ru, R 12 , R 20 , R 30 , and R 40 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 1 -C 60 alkylthio group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkylaryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —N(Q 1 )(Q 2 ), —Si(Q 3 )(Q 4 )(Q 5 ), —B(Q 6 )(Q 7 ), or —P(═O)(Q 8 )(Q 9 ), two or more of neighboring R 1 to R 4 , R 20 , R 30 , and R 40 are optionally linked together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group, b1 and b3 are each independently an integer from 1 to 5, when b1 is 2 or more, two or more of R 1 (s) are identical to or different from each other, and when b3 is 2 or more, two or more of R 3 (s) are identical to or different from each other, b20, b30, and b40 are each independently an integer from 1 to 10, when b20 is 2 or more, two or more R 20 (s) are identical to or different from each other, when b30 is 2 or more, two or more R 30 (s) are identical to or different from each other, and when b40 is 2 or more, two or more R 40 (s) are identical to or different from each other, * and *′ each indicate a binding site to a neighboring atom, at least one substituent of the substituted C 5 -C 30 carbocyclic group, the substituted C 1 -C 30 heterocyclic group, the substituted C 1 -C 60 alkyl group, the substituted C 6 -C 60 alkyl group, the substituted C 2 -C 60 alkenyl group, the substituted C 2 -C 60 alkynyl group, the substituted C 1 -C 60 alkoxy group, the substituted C 1 -C 60 alkylthio group, the substituted C 3 -C 10 cycloalkyl group, the substituted C 1 -C 10 heterocycloalkyl group, the substituted C 3 -C 10 cycloalkenyl group, the substituted C 2 -C 10 heterocycloalkenyl group, the substituted C 6 -C 60 aryl group, the substituted C 7 -C

Assignees

Inventors

Classifications

  • H10K85/346Primary

    comprising platinum · CPC title

  • C09B57/00Primary

    Other synthetic dyes of known constitution · CPC title

  • Platinum compounds · CPC title

  • Metal complexes of organic compounds not being dyes in uncomplexed form · CPC title

  • containing organic luminescent materials · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11832509B2 cover?
Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound. M 1 (L 11 ) n11 (L 12 ) n12   <Formula 1> wherein L 11 in Formula 1 is a ligand represented by Formula 1-1, and the descriptions of other substituents are the same as described in…
Who is the assignee on this patent?
Samsung Electronics Co Ltd
What technology area does this patent fall under?
Primary CPC classification H10K85/346. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).